COMP <GO>
ASML vs PLTR // RETURN ON INVESTED CAPITAL (ROIC)
ASML Holding N.V. New York Registry Shares (NASDAQ) VS. Palantir Technologies Inc. (NASDAQ) • 15-METRIC TALLY: ASML 4
— PLTR 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PLTR
LAST: $1,565.90 (-6.55%) • MKT CAP: $645.84B
roic
14.90%
LAST: $184.11 (-6.27%) • MKT CAP: $471.81B
roic
26.88%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASML VS. PLTR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASML | PLTR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 84.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 14.90% | 26.88% | -11.98 | PLTR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | 157.6x | -142.67 | ASML | /valuation <GO> |
| Free Cash Flow Yield | 3.99% | 0.76% | +3.23 | ASML | /fcf-yield <GO> |
| Operating Margin | 21.10% | 42.80% | -21.70 | PLTR | /operating-margins <GO> |
| Net Profit Margin | 16.40% | 49.00% | -32.60 | PLTR | /net-margins <GO> |
| Revenue Growth (YoY) | -4.40% | 78.92% | -83.32 | PLTR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.87 | 17.06 | -13.19 | PLTR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | PLTR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 14.35% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.0 | 59.2 | -9.20 | PLTR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.31 | 2.17 | -0.86 | PLTR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 83.7x | -63.53 | ASML | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $645.84B | $471.81B | $174.03B | ASML | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASML REV | PLTR REV | ASML GROSS % | PLTR GROSS % | ASML FCF | PLTR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $4.48B | — | 82.4% | — | $2.10B |
| FY 2024 | — | $2.87B | — | 80.3% | — | $1.14B |
| FY 2023 | — | $2.23B | — | 80.6% | — | $697.1M |
| FY 2022 | — | $1.91B | — | 78.6% | — | $183.7M |
| FY 2021 | — | $1.54B | — | 78.0% | — | $321.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASML // BETA 1.31
PLTR // BETA 2.17